Enzo Biochem, Inc. (ENZ) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Enzo Biochem, Inc. (ENZ) Bundle
Discover the true potential of Enzo Biochem, Inc. (ENZ) with our professional-grade DCF Calculator! Adjust key assumptions, explore various scenarios, and examine how changes affect Enzo Biochem's valuation – all within a single Excel template.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 76.0 | 117.7 | 107.1 | 31.1 | 31.9 | 30.1 | 28.4 | 26.8 | 25.3 | 23.9 |
Revenue Growth, % | 0 | 54.87 | -9.05 | -70.99 | 2.72 | -5.61 | -5.61 | -5.61 | -5.61 | -5.61 |
EBITDA | -27.6 | 3.3 | -15.0 | -20.9 | -8.3 | -8.5 | -8.0 | -7.6 | -7.1 | -6.7 |
EBITDA, % | -36.29 | 2.84 | -14.02 | -67.42 | -26.16 | -28.21 | -28.21 | -28.21 | -28.21 | -28.21 |
Depreciation | 2.8 | 2.7 | 2.8 | 2.7 | 1.3 | 1.3 | 1.2 | 1.1 | 1.1 | 1.0 |
Depreciation, % | 3.66 | 2.25 | 2.64 | 8.63 | 3.99 | 4.23 | 4.23 | 4.23 | 4.23 | 4.23 |
EBIT | -30.4 | .7 | -17.8 | -23.6 | -9.6 | -9.8 | -9.2 | -8.7 | -8.2 | -7.8 |
EBIT, % | -39.95 | 0.58778 | -16.66 | -76.05 | -30.15 | -32.44 | -32.44 | -32.44 | -32.44 | -32.44 |
Total Cash | 47.9 | 43.5 | 21.6 | 82.4 | 52.4 | 19.3 | 18.2 | 17.2 | 16.2 | 15.3 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 9.1 | 10.2 | 4.8 | 4.8 | 4.0 | 3.2 | 3.0 | 2.8 | 2.7 | 2.5 |
Account Receivables, % | 12.02 | 8.66 | 4.45 | 15.48 | 12.5 | 10.62 | 10.62 | 10.62 | 10.62 | 10.62 |
Inventories | 7.8 | 12.7 | 15.4 | 7.9 | 6.8 | 5.0 | 4.7 | 4.4 | 4.2 | 3.9 |
Inventories, % | 10.24 | 10.75 | 14.39 | 25.56 | 21.41 | 16.47 | 16.47 | 16.47 | 16.47 | 16.47 |
Accounts Payable | 8.5 | 8.1 | 3.7 | 3.6 | 1.4 | 2.3 | 2.1 | 2.0 | 1.9 | 1.8 |
Accounts Payable, % | 11.19 | 6.9 | 3.47 | 11.51 | 4.31 | 7.48 | 7.48 | 7.48 | 7.48 | 7.48 |
Capital Expenditure | -2.2 | -4.4 | -3.5 | -2.8 | -.5 | -1.2 | -1.2 | -1.1 | -1.0 | -1.0 |
Capital Expenditure, % | -2.85 | -3.77 | -3.24 | -8.89 | -1.71 | -4.09 | -4.09 | -4.09 | -4.09 | -4.09 |
Tax Rate, % | -165.64 | -165.64 | -165.64 | -165.64 | -165.64 | -165.64 | -165.64 | -165.64 | -165.64 | -165.64 |
EBITAT | -36.1 | .3 | -22.1 | 19.2 | -25.6 | -6.7 | -6.3 | -6.0 | -5.6 | -5.3 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -43.9 | -7.8 | -24.4 | 26.4 | -25.1 | -3.1 | -6.0 | -5.6 | -5.3 | -5.0 |
WACC, % | 7.69 | 7.42 | 7.69 | 7.21 | 7.69 | 7.54 | 7.54 | 7.54 | 7.54 | 7.54 |
PV UFCF | ||||||||||
SUM PV UFCF | -20.1 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -5 | |||||||||
Terminal Value | -92 | |||||||||
Present Terminal Value | -64 | |||||||||
Enterprise Value | -84 | |||||||||
Net Debt | -49 | |||||||||
Equity Value | -35 | |||||||||
Diluted Shares Outstanding, MM | 51 | |||||||||
Equity Value Per Share | -0.69 |
What You Will Get
- Real ENZ Financials: Access to historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed automatically.
- Scenario Analysis: Explore various scenarios to assess Enzo Biochem's future performance.
- User-Friendly Design: Designed for professionals while remaining easy for newcomers.
Key Features
- Customizable Research Parameters: Adjust essential inputs such as revenue projections, gross margins, and R&D expenses.
- Instant DCF Valuation: Quickly computes intrinsic value, NPV, and various financial metrics.
- High-Precision Accuracy: Incorporates Enzo Biochem’s real-world financial data for credible valuation results.
- Effortless Scenario Analysis: Evaluate different hypotheses and analyze results with ease.
- Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.
How It Works
- Download: Access the ready-to-use Excel file containing Enzo Biochem, Inc.'s (ENZ) financial data.
- Customize: Modify forecasts, such as revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate multiple projections and compare results instantly.
- Make Decisions: Utilize the valuation outcomes to inform your investment strategy.
Why Choose This Calculator for Enzo Biochem, Inc. (ENZ)?
- Accurate Data: Real Enzo Biochem financials provide dependable valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Built-in calculations save you the hassle of starting from the ground up.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants focused on biotech.
- User-Friendly: Easy-to-navigate design and step-by-step guidance cater to users of all experience levels.
Who Should Use This Product?
- Investors: Evaluate Enzo Biochem's valuation before making stock trades.
- CFOs and Financial Analysts: Enhance valuation methodologies and assess financial forecasts.
- Startup Founders: Understand the valuation strategies of established biotech companies like Enzo Biochem.
- Consultants: Provide expert valuation assessments for clients in the biotech sector.
- Students and Educators: Utilize current data to learn and teach valuation practices in biotechnology.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for Enzo Biochem, Inc. (ENZ).
- Real-World Data: Enzo Biochem’s historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Visualizations such as charts and tables for clear, actionable results.